CutisPharma, Inc. announced today its acquisition of Silvergate Pharmaceuticals, Inc. and the unveiling of its new corporate brand for the unified company: Azurity Pharmaceuticals.
Date: June 17, 2019
Source: CutisPharma
Coffee with DistilINFO's Morning Updates...
Sign up for DistilINFO e-Newsletters.
Related Stories
Chinese Insurtech Startup Carevoice Lands Roughly $10M
UK Medical 3D Printing Startup axial3D Lands $3M to Support US Expansion
NuvoAir App Records Coughing to Help Diagnose Respiratory Conditions
AliveCor, AstraZeneca Partner to Screen for Blood Potassium Levels Via Electrocardiograms
Private equity firm considering sale of HealthChannels’ 4 revenue cycle companies
Zambon Completes Transformational Acquisition of Breath Therapeutics
Actelion chief seeks “nirvana state” of better PAH diagnoses
HeartBeam Announces Acquisition of LIVMOR Assets